Skip to content

The Efficacy of REHACOP Program in Schizophrenia

Implementation of REHACOP Cognitive Training Program in Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02796417
Acronym
CSrehacopSZ
Enrollment
111
Registered
2016-06-10
Start date
2012-03-31
Completion date
2014-04-30
Last updated
2016-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

This study examined the efficacy of an integrative cognitive remediation program (REHACOP) to improve cognition, social cognition, clinical symptoms and functional outcome in patients with schizophrenia.

Interventions

BEHAVIORALREHACOP

REHACOP group consists of 90-minute-long sessions 3 days per week. Specifically, REHACOP group remediation consisted of: Attention unit (4 weeks) training sustained, selective, alternant and divided attention; Memory unit (3 weeks) focusing on visual and verbal learning, recall and recognizing memory; Language unit (3 weeks) including grammar, syntax, vocabulary, verbal fluency, verbal comprehension, abstract language; Executive functions unit (2 weeks) training cognitive planning, proverbs, analogies; and Social cognition unit (1 week) exercising theory of mind, social reasoning and moral dilemmas

Occupational group activities conducted included drawing, gardening, reading the daily news and constructing using different materials (such as paper or wood).

Sponsors

University of Deusto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* diagnostic criteria for Schizophrenia according to American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

Exclusion criteria

* evidence of alcohol or drug abuse in the last 30 days * previous history of significant lack of consciousness * mental retardation * relevant neurological or medical condition

Design outcomes

Primary

MeasureTime frameDescription
change in verbal memory after receiving cognitive remediation4 monthsVerbal memory performance was assessed with the Hopkins Verbal Learning Test-HVLT (Brandt and Benedict 2001)
change in processing speed after receiving cognitive remediation4 monthsProcessing speed was assessed with Digit Symbol subtest from Wechsler Adult Intelligence Scale-III (Wechsler 1997)
Change in functional competence after receiving cognitive remediation4 monthsfunctional competence was measured with San Diego UCSD Performance-Based Skills Assessment- UPSA
Change in global functioning after receiving cognitive remediation4 monthsglobal functioning measured with Global Assessment of Functioning (GAF)

Secondary

MeasureTime frameDescription
change in emotion perception after receiving cognitive remediation4 monthsemotion perception was assessed with Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT)
change in clinical symptoms after receiving cognitive remediation4 monthsClinical symptoms was measured with Positive and Negative Syndrome Scale (PANSS)
change in social perception after receiving cognitive remediation4 monthsSocial perception was assessed with the Social Featuring Recognition Test (SFRT)
change in theory of mind after receiving cognitive remediation4 monthsTheory of mind was assessed with Happe Strange Stories Test

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026